Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M

Moderna is buying Japanese DNA supplier OriCiro Genomics K.K. for $85 million, the U.S. company’s first acquisition since launching in 2010. It’s not the major splash that some may have expected, or even hoped for, but in many ways it fits the tea leaves executives had teased all last year.